Ana Rocha and Martim Bouza Serrano, Senior Associate and Coordinator Associate of CCA ONTIER's Data Protection Team, wrote an opinion piece for the Pharmaceutical News about the new General Data Protection Regulation, which will be applicable in May 2018 , and its impact on health and life sciences, as well as on the pharmaceutical industry.
'It is essential for companies to review their privacy policies, procedures and mechanisms, internalize the principles and realize that being in tune with the RGPD is more than ever a competitive advantage today,' claim the lawyers.
To read in full here: